Genetic Studies of Campylobacter rectus Campylobacter rectus in an anaerobic Gram negative, motile rod which is often isolated from adult periodontitis lesions including periodontitis lesions found in patients with systemic diseases such as diabetes mellitus and Acquired Immunodeficiency Syndrome. While cross-sectional studies implicate this species as an important periodontal pathogen, relatively little is know about C. rectus. Identification of virulence factors would be an important step in elucidating the role this organism plays in the pathogenesis of periodontal disease. One potential virulence factor from C. rectus is a toxin which kills human polymorphonuclear leukocytes and promyelocytic HL-60 cells and which may allow C. rectus to overcome host defenses and to colonize the periodontium. The long term objective of these studies is to gain a better understanding of the role of C. rectus in human periodontal disease and in extraoral infections and then to develop strategies for the control and prevention of C. rectus associated periodontitis. Specifically we propose to; (1) examine genetic and serologic heterogeneity within C. rectus, (2) clone the toxin gene into E. Coli; (3) determine the structure and transcriptional organization of the gene or genes responsible for the toxin production, and; (4) study the structure/function relationships of the toxin gene product. Key Words: Campylobacter rectus, toxin, cloning

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
5K16DE000158-09
Application #
3775569
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1993
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Type
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Krebs, Linda J; Wang, Xiaopeng; Nagy, Atilla et al. (2002) Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro. Int J Oncol 21:1325-9
Krebs, Linda J; Wang, Xiaopeng; Nagy, Attila et al. (2002) A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancers. Oral Oncol 38:657-663
Rogers, J D; Scannapieco, F A (2001) RegG, a CcpA homolog, participates in regulation of amylase-binding protein A gene (abpA) expression in Streptococcus gordonii. J Bacteriol 183:3521-5
Krebs, L J; Wang, X; Pudavar, H E et al. (2000) Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor. Cancer Res 60:4194-9
Malek, R; Fisher, J G; Caleca, A et al. (1994) Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176:1052-9
Dolce, C; Anguita, J; Brinkley, L et al. (1994) Effects of sialoadenectomy and exogenous EGF on molar drift and orthodontic tooth movement in rats. Am J Physiol 266:E731-8
Stephan, E B; Dziak, R (1994) Effects of genistein, tyrphostin, and pertussis toxin on EGF-induced mitogenesis in primary culture and clonal osteoblastic cells. Calcif Tissue Int 54:409-13
Grossi, S G; Zambon, J J; Ho, A W et al. (1994) Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65:260-7
Winston, J L; Chen, C K; Neiders, M E et al. (1993) Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability. J Dent Res 72:1366-73
Sharma, A; Sojar, H T; Lee, J Y et al. (1993) Expression of a functional Porphyromonas gingivalis fimbrillin polypeptide in Escherichia coli: purification, physicochemical and immunochemical characterization, and binding characteristics. Infect Immun 61:3570-3

Showing the most recent 10 out of 24 publications